Author:
Mu Ya-Fan,Gao Zhong-Xiuzi,Mao Zi-Hui,Pan Shao-Kang,Liu Dong-Wei,Liu Zhang-Suo,Wu Peng
Publisher
Springer Science and Business Media LLC
Reference120 articles.
1. Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022;328:1849.
2. Xie Y, Qi H, Peng W, Li B, Wen F, Zhang F, et al. SNPs in lncRNA KCNQ1OT1 modulate its expression and confer susceptibility to salt sensitivity of blood pressure in a Chinese Han population. Nutrients. 2022;14:3990.
3. Mente A, O’Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392:496–506.
4. Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20:103.
5. Wu Q, Yang H, Zheng Q, Chen Q, Li X, Guo J. κ-Opioid receptors improve vascular endothelial dysfunction in salt-sensitive hypertension via PI3K/Akt/eNOS signaling pathway. Oxid Med Cell Longev. 2023;2023:1–13.